145 related articles for article (PubMed ID: 26552149)
1. [Design, synthesis and antiproliferative activities of artemisinin derivatives substituted by N-heterocycles].
Zuo ZZ; Zhong H; Cai T; Bao Y; Liu ZQ; Liu D; Zhao LX
Yao Xue Xue Bao; 2015 Jul; 50(7):868-74. PubMed ID: 26552149
[TBL] [Abstract][Full Text] [Related]
2. Artemisinin-indole and artemisinin-imidazole hybrids: Synthesis, cytotoxic evaluation and reversal effects on multidrug resistance in MCF-7/ADR cells.
Hu Y; Li N; Zhang J; Wang Y; Chen L; Sun J
Bioorg Med Chem Lett; 2019 May; 29(9):1138-1142. PubMed ID: 30837097
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.
Gaur R; Pathania AS; Malik FA; Bhakuni RS; Verma RK
Eur J Med Chem; 2016 Oct; 122():232-246. PubMed ID: 27371926
[TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis and antiproliferative activity in cancer cells of novel dihydropyrazolyl and pyrazolyl artemisinin-phenyl ethers].
Wei YF; Huang M; Li AH; Zhao F; Zhong H; Liu D; Zhao LX
Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(17):3582-3588. PubMed ID: 30347929
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton.
Ha VT; Kien VT; Binh le H; Tien VD; My NT; Nam NH; Baltas M; Hahn H; Han BW; Thao do T; Vu TK
Bioorg Chem; 2016 Jun; 66():63-71. PubMed ID: 27018835
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
Luan S; Zhong H; Zhao X; Yang J; Jing Y; Liu D; Zhao L
Eur J Med Chem; 2017 Dec; 141():584-595. PubMed ID: 29102180
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells.
Yang X; Wang W; Tan J; Song D; Li M; Liu D; Jing Y; Zhao L
Bioorg Med Chem Lett; 2009 Aug; 19(15):4385-8. PubMed ID: 19501507
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Antitumor Activities of Isomers of Artemisinin Dimer Derivatives.
Yue L; Pan Y; Wang J; Yue L; Luo Y; Lv F; Lv J; Chen J; Zhao Q; Lin H
Chem Biodivers; 2023 Jul; 20(7):e202300615. PubMed ID: 37256824
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer.
Fröhlich T; Mai C; Bogautdinov RP; Morozkina SN; Shavva AG; Friedrich O; Gilbert DF; Tsogoeva SB
ChemMedChem; 2020 Aug; 15(15):1473-1479. PubMed ID: 32374071
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity of novel 10-substituted dihydroartemisinin derivatives containing N-arylphenyl-ethenesulfonamide groups.
Liu Y; Liu Z; Shi J; Chen H; Mi B; Li P; Gong P
Molecules; 2013 Mar; 18(3):2864-77. PubMed ID: 23459298
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2019 Nov; 182():111665. PubMed ID: 31494469
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents.
Li S; Li G; Yang X; Meng Q; Yuan S; He Y; Sun D
Bioorg Med Chem Lett; 2018 Jul; 28(13):2275-2278. PubMed ID: 29789258
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
15. Combating P-glycoprotein-mediated multidrug resistance with 10-O-phenyl dihydroartemisinin ethers in MCF-7 cells.
Zhong H; Zhao X; Zuo Z; Sun J; Yao Y; Wang T; Liu D; Zhao L
Eur J Med Chem; 2016 Jan; 108():720-729. PubMed ID: 26741854
[TBL] [Abstract][Full Text] [Related]
16. Antitumour and antimalarial activity of artemisinin-acridine hybrids.
Jones M; Mercer AE; Stocks PA; La Pensée LJ; Cosstick R; Park BK; Kennedy ME; Piantanida I; Ward SA; Davies J; Bray PG; Rawe SL; Baird J; Charidza T; Janneh O; O'Neill PM
Bioorg Med Chem Lett; 2009 Apr; 19(7):2033-7. PubMed ID: 19249201
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of a series of non-hemiacetal ester derivatives of artemisinin.
Zuma NH; Smit FJ; de Kock C; Combrinck J; Smith PJ; N'Da DD
Eur J Med Chem; 2016 Oct; 122():635-646. PubMed ID: 27448920
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity.
Wei MX; Yu JY; Liu XX; Li XQ; Zhang MW; Yang PW; Yang JH
Eur J Med Chem; 2021 Apr; 215():113295. PubMed ID: 33636536
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of artemisinin dimers using the Ugi reaction and their in vitro efficacy on breast cancer cells.
Wang S; Sasaki T
Bioorg Med Chem Lett; 2013 Aug; 23(15):4424-7. PubMed ID: 23790541
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics.
Chekhun VF; Lukianova NY; Borikun TV; Zadvorny TV; Mokhir A
Exp Oncol; 2017 Mar; 39(1):25-29. PubMed ID: 28361857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
